Prostate MRI · PI-RADS v2.1 + Local Staging & Post-Treatment Assessment
Structured reporting for detection, risk stratification, local staging, and post-treatment evaluation of prostate cancer.
Highest PI-RADS
—
ISUP Grade Group
—
PSA density
—
PSA ÷ volume
EPE Risk
—
Imaging-based
SVI Risk
None recorded
Clinical Stage
—
Treatment Status
Treatment-naïve
PSA (ng/mL)
Volume (cc)
Biopsy history
Prior Gleason GG
Active surveillance
Prior treatment
🧬
Histopathology & ISUP Grade Group
Select the current Gleason grade group.
Enter PSA and prostate volume to compute PSA density.
Scoring cards live inside each lesion. Switch lesions to update the T2 / DWI panels.
Zone
Side
Level
A/P
Clock
Size (mm)
Urethra
Capsule
Invasive behavior(frank EPE / SVI / neurovascular invasion visible)
T2WI Score
Transition zone dominant
DWI Score
Peripheral zone dominant
Dynamic contrast (DCE)
Computed category
—
Why this score? Select a zone (PZ, TZ, CZ, or AFMS).
Capsular contact (mm)
Contact threshold (mm)(configurable)
Capsular bulge
Capsular irregularity
Capsular breach(definite EPE)
Measurable extraprostatic tumor
NVB asymmetry
Rectoprostatic angle obliteration
Imaging-based EPE risk estimate
—
- • No EPE signals recorded
Node classification uses morphology + diffusion + PSMA correlation. Short-axis size alone is not sufficient.
PSMA PET available
MRI ↔ PSMA correlation
MRI–Pathology concordance
Enter Gleason grade group (and optionally prior GG) to evaluate concordance.
Active lesion
Lesion 1 · unspecified location
Final impression banner
Add a scored lesion to generate the final assessment.
Auto-generated impression
Add a scored lesion to generate the final assessment.
Recommended next steps
Recommendations become available once a lesion is characterized.
Structured report
PROSTATE MRI — PI-RADS v2.1 STRUCTURED REPORT Lesions: 1. unspecified location — T2 —, DWI —, DCE — → PI-RADS —